Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma
详细信息 查看全文
- 作者：Masataka Okuno ; Tomoki Ebata ; Yukihiro Yokoyama…
- 关键词：Glasgow Prognostic Score ; Systemic inflammatory response ; C ; reactive protein ; Surgical treatment ; Prognosis
- 刊名：Journal of Gastroenterology
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：51
- 期：2
- 页码：153-161
- 全文大小：598 KB
- 参考文献：1.Proctor MJ, Talwar D, Balmar SM, et al. The relationship between the presence and site of cancer, an inflammatory-based prognostic score and biochemical parameters: initial results of the Glasgow Inflammatory Outcome Study. Br J Cancer. 2010;103:870–6.PubMedCentral CrossRef PubMed
2.Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumor site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104:726–34.PubMedCentral CrossRef PubMed
3.Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer: a Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47:2633–41.CrossRef PubMed
4.McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–40.CrossRef PubMed
5.Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4.CrossRef PubMed
6.Malietzis G, Giacometti M, Askari A, et al. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg. 2014;260:287–92.CrossRef PubMed
7.Templeton AJ, McNamara MG, Seruqa B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.CrossRef PubMed
8.Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–72.CrossRef PubMed
9.Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyre ration (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58.PubMedCentral CrossRef PubMed
10.Onodera T, Goseki N, Kosaki G. (Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients). Nippon Geka Gakkai Zasshi. 1984;85:1001–5 (in Japanese with English abstract).PubMed
11.Nozoe T, Kohno M, Iguchi T, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42:532–5.CrossRef PubMed
12.Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98:268–74.CrossRef PubMed
13.Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–73.PubMedCentral CrossRef PubMed
14.Ebata T, Kamiya J, Nishio H, et al. The concept of perihilar cholangiocarcinoma is valid. Br J Surg. 2009;96:926–34.CrossRef PubMed
15.Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115–23.CrossRef PubMed
16.Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Surg. 2010;17:476–89.CrossRef
17.van Gulik TM, Kloek JJ, Ruys AT, Busch ORC, van Tienhoven GJ, Lameris JS, et al. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol. 2011;37:65–71.CrossRef PubMed
18.Young AL, Igami T, Senda Y, et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western center demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxf). 2011;13:483–93.CrossRef
19.Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129–40.CrossRef PubMed
20.Dumitrascu T, Chirta D, Lonescu M, et al. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17:913–24.CrossRef PubMed
21.Oshiro Y, Sasaki R, Fukunaga K, et al. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2013;20:389–95.CrossRef PubMed
22.Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg. 2013;257:121–7.CrossRef PubMed
23.Kanai M, Nimura Y, Kamiya J, et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery. 1996;119:498–504.CrossRef PubMed
24.Yokoyama Y, Ebata T, Igami T, et al. The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery. 2014;156(5):1190–6.CrossRef PubMed
25.Kamiya S, Nagino M, Kanazawa H, et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg. 2004;239:510–7.PubMedCentral CrossRef PubMed
26.Nagino M, Nimura Y, Kamiya J, et al. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996;200:559–63.CrossRef PubMed
27.Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.PubMedCentral CrossRef PubMed
28.Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.CrossRef PubMed
29.Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCentral CrossRef PubMed
30.Gerhardt T, Milz S, Schpke M, et al. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol. 2006;12:5495–500.PubMedCentral PubMed
31.McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90:215–9.CrossRef PubMed
32.Castell JV, Gómez-Lechón MJ, David M, et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12:1179–86.CrossRef PubMed
33.Okada K, Shimizu Y, Nambu S, et al. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol. 1994;9:462–7.CrossRef PubMed
34.Nozoe T, Iguchi T, Egashira A, et al. Significance of modified Glasgow score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg. 2011;201:186–91.CrossRef PubMed
35.Jiang X, Hiki N, Nunobe S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275–9.PubMedCentral CrossRef PubMed
36.Wang DS, Ren C, Qui MZ, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumor Biol. 2012;33:749–56.CrossRef
37.Ishizuka M, Nagata H, Takagi K, et al. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047–51.CrossRef PubMed
38.Letch FF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97:1266–70.CrossRef
39.Choi KW, Hong SW, Chang YG, et al. Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res. 2014;86:309–13.PubMedCentral CrossRef PubMed
40.Nagino M. Perihilar cholangiocarcinoma: surgeon’s view point on current topics. J Gastroenterol. 2012;47:1165–76.CrossRef PubMed - 作者单位：Masataka Okuno (1)
Tomoki Ebata (1)
Yukihiro Yokoyama (1)
Tsuyoshi Igami (1)
Gen Sugawara (1)
Takashi Mizuno (1)
Junpei Yamaguchi (1)
Masato Nagino (1)
1. Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Gastroenterology
Oncology
Surgical Oncology
Hepatology
Internal Medicine
Colorectal Surgery - 出版者：Springer Japan
- ISSN：1435-5922
文摘
Background Inflammation-based prognostic scores have prognostic value in several kinds of cancer. However, little is known about their value in perihilar cholangiocarcinoma. We evaluated whether inflammation-based prognostic scores are associated with survival of patients with perihilar cholangiocarcinoma.